ACM
JAZZ icon

Aster Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Aster Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Buy
1,578
+1,438
+1,027% +$315K 0.08% 313
2026
Q1 		$17.4K Sell
140
-37
-21% -$6.47K 0.01% 570
2025
Q4 		$30.1K Sell
177
-155
-47% -$23.8K 0.01% 545
2025
Q3 		$43.8K Sell
332
-105
-24% -$12.6K 0.02% 522
2025
Q2 		$46.4K Sell
437
-10,936
-96% -$1.19M 0.01% 614
2025
Q1 		$1.63M Buy
+11,373
New +$1.48M 0.3% 79

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Aster Capital Management's JAZZ Position: Q2 2026 in Review

Aster Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 1,027% in Q2 2026, buying an estimated $315K and bringing the position to 1,578 shares worth $380K. The position accounts for 0.08% of the portfolio, ranked #313.

Aster Capital Management first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.63M in Q1 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Aster Capital Management held 1,578 shares of Jazz Pharmaceuticals worth $380K as of Q2 2026.
  • Aster Capital Management bought 1,438 Jazz Pharmaceuticals shares in Q2 2026, an estimated $315K.
  • Jazz Pharmaceuticals made up 0.08% of Aster Capital Management's portfolio in Q2 2026, its #313 holding.
  • Aster Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Aster Capital Management's Jazz Pharmaceuticals position peaked at $1.63M in Q1 2025.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.